Role of PET/CT in Management of Chest Tumors
Nabil, H., Maher, K., Mahdy, S., Sakr, H., Abdel Karim, K. (2013). Role of PET/CT in Management of Chest Tumors. EKB Journal Management System, 53(1), 816-826. doi: 10.12816/0001644
Heba Nabil; Karima M Maher; Sameh AR Mahdy; Hossam M Sakr; Khalid Abdel Karim. "Role of PET/CT in Management of Chest Tumors". EKB Journal Management System, 53, 1, 2013, 816-826. doi: 10.12816/0001644
Nabil, H., Maher, K., Mahdy, S., Sakr, H., Abdel Karim, K. (2013). 'Role of PET/CT in Management of Chest Tumors', EKB Journal Management System, 53(1), pp. 816-826. doi: 10.12816/0001644
Nabil, H., Maher, K., Mahdy, S., Sakr, H., Abdel Karim, K. Role of PET/CT in Management of Chest Tumors. EKB Journal Management System, 2013; 53(1): 816-826. doi: 10.12816/0001644

Role of PET/CT in Management of Chest Tumors

The Egyptian Journal of Hospital Medicine
Article 9, Volume 53, Issue 1, October 2013, Page 816-826  XML PDF (698.11 K)
Document Type: Original Article
DOI: 10.12816/0001644
View on SCiNiTO View on SCiNiTO
Authors
Heba Nabil1; Karima M Maher2; Sameh AR Mahdy2; Hossam M Sakr2; Khalid Abdel Karim3
1Nasser Institute Hospital for Research and Treatment, Cairo, Egypt
2Radiodiagnosis Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
3Clinical Oncology Depatment, Faculty of Medicine, Ain Shams University, Cairo, Egypt
Abstract
ABSTRACT
OBJECTIVE: to identify the role of PET-CT in management of chest tumors.
PATIENTS AND METHODS: Whole body PET/CT study was performed on 32 patients of variable primary & secondary chest tumors who were under evaluation for primary or secondary chest tumors by recent CT, referred for staging before treatment and / or follow up after treatment.
RESULTS: Our findings indicate  that FDG PET/CT has an important  impact  on diagnosis & management of chest tumors , as it delineated the metabolic activity of the disease in 19 patients (59.4 %), outlined  the metabolic activity of the tumoral residue in 6 patients (18.75%) , differentiated between tumoral residue & post irradiation pneumonitis in 1 patient (3.1%), followed up  the therapeutic response in 4 patients (12.5 %), differentiated  between residual mass & post therapeutic fibrosis in 1 patient (3.1%) and delineated the metabolic activity of the disease for preparing for BMT in  1 patient (3.1%) and so had an impact on  the management of chest tumor patients.
 CONCLUSION:  By recognizing the relevant radiologic and metabolic behavior of chest tumors, understanding the appropriateness of staging disease with the TNM classification system, and being familiar with potential imaging pitfalls, PET/CT can make an important contribution to diagnosis, treatment and outcome in chest tumor patients.
 
Keywords
PET/CT – Chest Tumors – Management
Statistics
Article View: 86
PDF Download: 243